2462. Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW-TT) Administered in Individuals 56 Years of Age and Older

por Jeanfreau, Robert, Esteves-Jaramillo, Alejandra, Neveu, David, Jordanov, Emilia, Dhingra, Mandeep S
Publicado 2018

Safety and Immunogenicity of a Full-dose, Split-virion, Inactivated, Quadrivalent Influenza Vaccine in Healthy Children 6-35 Months of Age: A Randomized Controlled Clinical Trial

por Robertson, Corwin A., Mercer, Monica, Selmani, Alexandre, Klein, Nicola P., Jeanfreau, Robert, Greenberg, David P.
Publicado 2019

Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow‐fill‐seal device in adults: a randomized, active‐controlled study

por Sheldon, Eric A., Jeanfreau, Robert, Sliman, Joseph A., Charenkavanich, Supoat, Rousculp, Matthew D., Dubovsky, Filip, Mallory, Raburn M.
Publicado 2012

Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study

por Áñez, Germán, Hedrick, James, Simon, Michael W., Christensen, Shane, Jeanfreau, Robert, Yau, Eddy, Pan, Judy, Jordanov, Emilia, Dhingra, Mandeep S.
Publicado 2020

AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

por Kosalaraksa, Pope, Jeanfreau, Robert, Frenette, Louise, Drame, Mamadou, Madariaga, Miguel, Innis, Bruce L., Godeaux, Olivier, Izurieta, Patricia, Vaughn, David W.
Publicado 2015

160. Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age

por Chang, Leejah, Anderson, Evan J, Jeanfreau, Robert, He, Ying, Hicks, Bryony, Shrestha, Anju, Pandey, Aseem, Khoury, Rawia, De Bruijn, Iris, Landolfi, Victoria
Publicado 2020

A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

por Pavia-Ruz, Noris, Angel Rodriguez Weber, Miguel, Lau, Yu-Lung, Nelson, E Anthony S, Kerdpanich, Angkool, Huang, Li-Min, Silas, Peter, Qaqundah, Paul, Blatter, Mark, Jeanfreau, Robert, Lei, Paul, Jain, Varsha, El Idrissi, Mohamed, Feng, Yang, Innis, Bruce, Peeters, Mathieu, Devaster, Jeanne-Marie
Publicado 2013

Time to Change Dosing of Inactivated Quadrivalent Influenza Vaccine in Young Children: Evidence From a Phase III, Randomized, Controlled Trial

por Jain, Varsha K., Domachowske, Joseph B., Wang, Long, Ofori-Anyinam, Opokua, Rodríguez-Weber, Miguel A., Leonardi, Michael L., Klein, Nicola P., Schlichter, Gary, Jeanfreau, Robert, Haney, Byron L., Chu, Laurence, Harris, Jo-Ann S., Sarpong, Kwabena O., Micucio, Amanda C., Soni, Jyoti, Chandrasekaran, Vijayalakshmi, Li, Ping, Innis, Bruce L.
Publicado 2017

Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia: A Randomized, Double-Blind, Placebo-controlled Trial

por Criner, Gerard J., Lang, Frederick M., Gottlieb, Robert L., Mathews, Kusum S., Wang, Tisha S., Rice, Todd W., Madduri, Deepu, Bellam, Shashi, Jeanfreau, Robert, Case, Amy H., Glassberg, Marilyn K., Lyon, George Marshall, Ahmad, Kareem, Mendelson, Robert, DiMaio, J. Michael, Tran, MaryAnn P., Spak, Cedric W., Abbasi, Jamil A., Davis, Steven G., Ghamande, Shekhar, Shen, Steven, Sherman, Lisa, Lowry, Simon
Publicado 2022

Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus Vaccine (RSVPreF3) in Mothers and Their Infants: A Phase 2 Randomized Trial

por Bebia, Zourab, Reyes, Osvaldo, Jeanfreau, Robert, Kantele, Anu, De Leon, Ruth Graciela, Sánchez, Marta García, Banooni, Peyman, Gardener, Glenn J, Rasero, José Luis Bartha, Pardilla, Maria Begoña Encinas, Langley, Joanne M, Di Leo, Claudio Maañón, Botelho-Nevers, Elisabeth, Buttery, Jim, Laurichesse, Helene, Madhi, Shabir A, García, Adrián Martín, Stanley, Thorsten, Barjat, Tiphaine, Griffith, Rebecca, Castrejón-Alba, Maria Mercedes, de Heusch, Magali, Dieussaert, Ilse, Hercor, Melanie, Lese, Patricia, Qian, Hui, Tullio, Antonella N, Henry, Ouzama
Publicado 2023

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico

por Dunkle, Lisa M., Kotloff, Karen L., Gay, Cynthia L., Áñez, Germán, Adelglass, Jeffrey M., Barrat Hernández, Alejandro Q., Harper, Wayne L., Duncanson, Daniel M., McArthur, Monica A., Florescu, Diana F., McClelland, R. Scott, Garcia-Fragoso, Veronica, Riesenberg, Robert A., Musante, David B., Fried, David L., Safirstein, Beth E., McKenzie, Mark, Jeanfreau, Robert J., Kingsley, Jeffrey K., Henderson, Jeffrey A., Lane, Dakotah C., Ruíz-Palacios, Guillermo M., Corey, Lawrence, Neuzil, Kathleen M., Coombs, Robert W., Greninger, Alex L., Hutter, Julia, Ake, Julie A., Smith, Katherine, Woo, Wayne, Cho, Iksung, Glenn, Gregory M., Dubovsky, Filip
Publicado 2021

Generation of recombinant hyperimmune globulins from diverse B-cell repertoires

por Keating, Sheila M., Mizrahi, Rena A., Adams, Matthew S., Asensio, Michael A., Benzie, Emily, Carter, Kyle P., Chiang, Yao, Edgar, Robert C., Gautam, Bishal K., Gras, Ashley, Leong, Jackson, Leong, Renee, Wearn Lim, Yoong, Manickam, Vishal A., Medina-Cucurella, Angelica V., Niedecken, Ariel R., Saini, Jasmeen, Fredrik Simons, Jan, Spindler, Matthew J., Stadtmiller, Kacy, Tinsley, Brendan, Wagner, Ellen K., Wayham, Nicholas, Tracy, LaRee, Vingsbo Lundberg, Carina, Büscher, Dirk, Vicente Terencio, Jose, Roalfe, Lucy, Pearce, Emma, Richardson, Hayley, Goldblatt, David, Ramjag, Anushka T., Carrington, Christine V.F., Simmons, Graham, Muench, Marcus O., Chamow, Steven M., Monroe, Bryan, Olson, Charles, Oguin, Thomas H., Lynch, Heather, Jeanfreau, Robert, Mosher, Rachel A., Walch, Matthew J., Bartley, Christopher R., Ross, Carl A., Meyer, Everett H., Adler, Adam S., Johnson, David S.
Publicado 2021